Egetis Therapeutics AB (publ) Net Asset Quality Index
Egetis Therapeutics AB (publ) net asset quality index. Egetis Therapeutics AB (publ) (EGTX) has a Net Asset Quality Index of 46.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr537.40 Million minus total liabilities of Skr288.70 Million yields net assets of Skr248.70 Million. A higher index indicates a stronger, lower-leverage balance sheet. See EGTX net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Egetis Therapeutics AB (publ) (2008–2025)
Net asset quality index of Egetis Therapeutics AB (publ) from 2008 to 2025. This chart shows how Egetis Therapeutics AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the index stands at 46.3%, representing net assets of Skr248.70 Million against total assets of Skr537.40 Million SEK. Check strategic asset allocation of Egetis Therapeutics AB (publ) to assess the company's strategic physical and investment asset allocation.
Egetis Therapeutics AB (publ) Net Asset Quality Index by Year (2008–2025)
Egetis Therapeutics AB (publ) net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Egetis Therapeutics AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Egetis Therapeutics AB (publ) (EGTX) total market value.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 53.0% | Skr338.70 Million | Skr639.10 Million | Skr300.40 Million | ▼ -9.2 pp |
| 2024 | 62.2% | Skr492.90 Million | Skr792.30 Million | Skr299.40 Million | ▼ -9.6 pp |
| 2023 | 71.8% | Skr545.60 Million | Skr760.20 Million | Skr214.60 Million | ▼ -18.4 pp |
| 2022 | 90.2% | Skr506.20 Million | Skr561.10 Million | Skr54.90 Million | ▼ -2.4 pp |
| 2021 | 92.6% | Skr527.04 Million | Skr569.27 Million | Skr42.23 Million | ▲ +22.2 pp |
| 2020 | 70.4% | Skr629.63 Million | Skr893.97 Million | Skr264.34 Million | ▼ -20.2 pp |
| 2019 | 90.7% | Skr244.88 Million | Skr270.07 Million | Skr25.20 Million | ▲ +0.0 pp |
| 2018 | 90.6% | Skr219.36 Million | Skr242.04 Million | Skr22.68 Million | ▼ -5.7 pp |
| 2017 | 96.3% | Skr303.71 Million | Skr315.37 Million | Skr11.66 Million | ▼ -2.0 pp |
| 2016 | 98.3% | Skr389.56 Million | Skr396.44 Million | Skr6.87 Million | ▲ +6.5 pp |
| 2015 | 91.7% | Skr48.03 Million | Skr52.36 Million | Skr4.33 Million | ▲ +4.1 pp |
| 2014 | 87.6% | Skr90.66 Million | Skr103.47 Million | Skr12.81 Million | ▼ -4.4 pp |
| 2013 | 92.0% | Skr46.95 Million | Skr51.01 Million | Skr4.06 Million | ▲ +2.8 pp |
| 2012 | 89.2% | Skr53.94 Million | Skr60.46 Million | Skr6.52 Million | ▼ -6.5 pp |
| 2011 | 95.7% | Skr87.53 Million | Skr91.42 Million | Skr3.89 Million | ▲ +13.4 pp |
| 2010 | 82.3% | Skr6.99 Million | Skr8.49 Million | Skr1.50 Million | ▼ -13.1 pp |
| 2009 | 95.4% | Skr5.64 Million | Skr5.91 Million | Skr273.98K | ▲ +1.4 pp |
| 2008 | 94.0% | Skr5.05 Million | Skr5.37 Million | Skr323.55K | — |